Log In
Print
BCIQ
Print
Print this Print this
 

ONT-380 (formerly ARRY-380)

  Manage Alerts
Collapse Summary General Information
Company Array BioPharma Inc.
DescriptionOral epidermal growth factor receptor 2 (EGFR2; HER2; ErbB2; neu) inhibitor
Molecular Target Epidermal growth factor receptor 2 (EGFR2) (HER2) (ErbB2) (neu)
Mechanism of ActionEpidermal growth factor (EGF) receptor 2 (HER2) (ErbB2) (neu) inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase I
Standard IndicationBreast cancer
Indication DetailsTreat HER2-positive metastatic breast cancer
Regulatory Designation

Partner

Oncothyreon Inc.


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today